Catherine M Preissig1, Mark R Rigby. 1. Department of Pediatrics, Division of Pediatric Critical Care Medicine, Emory University School of Medicine, Atlanta, GA, USA. Catherine.preissig@choa.org
Abstract
OBJECTIVE: To determine which children are susceptible to critical illness hyperglycemia (CIH) and whether CIH severity and duration correlate with diagnosis or illness severity. STUDY DESIGN: We developed a standard approach to identify and treat CIH in our medical/surgical pediatric intensive care unit. We define CIH as persistent blood glucose (BG) >140 mg/dL and titrate infused insulin to maintain BG 80 to 140 mg/dL. We conducted a retrospective analysis of patients with hyperglycemia from June 2006 through May 2007. Main outcomes were risk of development of CIH in different patient subgroups and CIH severity and duration. RESULTS: Average peak BG, CIH duration, and peak insulin requirements were 199 mg/dL, 6.3 days, and 0.09 units/kg/h, respectively, in patients with CIH. CIH severity and duration were highest in neurosurgical and patients with sepsis, those requiring mechanical ventilation and vasopressors, extracorporeal support, and those with highest illness severity scores. CONCLUSIONS: CIH severity and duration correlate with diagnosis and illness severity. Certain "risk factors" may be predictive of who develops CIH.
OBJECTIVE: To determine which children are susceptible to critical illness hyperglycemia (CIH) and whether CIH severity and duration correlate with diagnosis or illness severity. STUDY DESIGN: We developed a standard approach to identify and treat CIH in our medical/surgical pediatric intensive care unit. We define CIH as persistent blood glucose (BG) >140 mg/dL and titrate infused insulin to maintain BG 80 to 140 mg/dL. We conducted a retrospective analysis of patients with hyperglycemia from June 2006 through May 2007. Main outcomes were risk of development of CIH in different patient subgroups and CIH severity and duration. RESULTS: Average peak BG, CIH duration, and peak insulin requirements were 199 mg/dL, 6.3 days, and 0.09 units/kg/h, respectively, in patients with CIH. CIH severity and duration were highest in neurosurgical and patients with sepsis, those requiring mechanical ventilation and vasopressors, extracorporeal support, and those with highest illness severity scores. CONCLUSIONS:CIH severity and duration correlate with diagnosis and illness severity. Certain "risk factors" may be predictive of who develops CIH.
Authors: Marc G Jeschke; Gabriela A Kulp; Robert Kraft; Celeste C Finnerty; Ron Mlcak; Jong O Lee; David N Herndon Journal: Am J Respir Crit Care Med Date: 2010-04-15 Impact factor: 21.405
Authors: Stephen W Standage; Brock G Bennion; Taft O Knowles; Dolena R Ledee; Michael A Portman; John K McGuire; W Conrad Liles; Aaron K Olson Journal: Am J Physiol Heart Circ Physiol Date: 2016-11-23 Impact factor: 4.733
Authors: Garry M Steil; Jamin Alexander; Alexandra Papas; Langer Monica; Biren P Modi; Hannah Piper; Tom Jaksic; Rebecca Gottlieb; Michael S D Agus Journal: J Diabetes Sci Technol Date: 2011-01-01
Authors: Fnu Nagajyothi; Regina Kuliawat; Christine M Kusminski; Fabiana S Machado; Mahalia S Desruisseaux; Dazhi Zhao; Gary J Schwartz; Huan Huang; Chris Albanese; Michael P Lisanti; Rajat Singh; Feng Li; Louis M Weiss; Stephen M Factor; Jeffrey E Pessin; Philipp E Scherer; Herbert B Tanowitz Journal: Am J Pathol Date: 2013-01-12 Impact factor: 4.307